WMS Group LLC trimmed its holdings in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) by 60.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 59,416 shares of the company’s stock after selling 90,439 shares during the period. Invesco Nasdaq Biotechnology ETF makes up about 2.5% of WMS Group LLC’s holdings, making the stock its 16th biggest position. WMS Group LLC owned approximately 2.63% of Invesco Nasdaq Biotechnology ETF worth $1,722,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Independent Advisor Alliance acquired a new position in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at about $653,000. GeoWealth Management LLC acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF during the third quarter worth approximately $451,000. Orion Porfolio Solutions LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter valued at approximately $392,000. CreativeOne Wealth LLC acquired a new position in Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at approximately $286,000. Finally, Osaic Holdings Inc. increased its stake in Invesco Nasdaq Biotechnology ETF by 66.1% in the 4th quarter. Osaic Holdings Inc. now owns 7,989 shares of the company’s stock valued at $227,000 after buying an additional 3,178 shares during the period.
Invesco Nasdaq Biotechnology ETF Stock Up 2.3%
IBBQ stock opened at $32.23 on Friday. The company has a 50 day moving average of $29.65 and a two-hundred day moving average of $29.24. The company has a market cap of $72.84 million, a price-to-earnings ratio of 17.03 and a beta of 0.62. Invesco Nasdaq Biotechnology ETF has a 12-month low of $21.05 and a 12-month high of $32.37.
Invesco Nasdaq Biotechnology ETF Dividend Announcement
Invesco Nasdaq Biotechnology ETF Company Profile
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
See Also
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
- Palantir’s Valuation Problem Just Met 2 New Growth Catalysts
- Xcel Energy Stock Offers Stability as Electricity Demand Builds
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
